Alternative modulation of protein-protein interactions by small molecules.
Protein-protein interactions (PPI) have become increasingly popular drug targets, with a number of promising compounds currently in clinical trials. Recent research shows, that PPIs can be modulated in more ways than direct inhibition, where novel non-competitive modes of action promise a solution for the difficult nature of PPI drug discovery. Here, we review recently discovered PPI modulators in light of their mode of action and categorise them as disrupting versus stabilising, orthosteric versus allosteric and by their ability to affect the proteins' dynamics. We also give recent examples of compounds successful in the clinic, analyse their physicochemical properties and discuss how to overcome the hurdles in discovering alternative modes of modulation.
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Gerhard
G
Fischer
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.
Maxim
M
Rossmann
Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK. Electronic address: mh256@cam.ac.uk.
Marko
M
Hyvönen
D000494:Allosteric Regulation; D000818:Animals; D016503:Drug Delivery Systems; D055808:Drug Discovery; D006801:Humans; D011485:Protein Binding; D054852:Small Molecule Libraries / Q000378:metabolism
D054852:Small Molecule Libraries